Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ulrich Julius. (2016) Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection. Medical Devices: Evidence and Research 9, pages 349-360.
Read now
Read now
Articles from other publishers (26)
Tiziana Sampietro, Beatrice Dal Pino, Federico Bigazzi, Francesco Sbrana, Andrea Ripoli, Enrica Fontanelli, Mascia Pianelli, Roberta Luciani, Antonio Lepri & Giacomo Calzetti. (2023) Acute Increase in Ocular Microcirculation Blood Flow Upon Cholesterol Removal. The Eyes Are the Window of the Heart. The American Journal of Medicine 136:1, pages 108-114.
Crossref
Crossref
Solveig Frieda Rosa Kuss, Ulrike Schatz, Sergey Tselmin, Sabine Fischer & Ulrich Julius. (2022) The development of lipoprotein apheresis in Saxony in the last years. Therapeutic Apheresis and Dialysis 26:S1, pages 53-63.
Crossref
Crossref
Tiziana Sampietro, Francesco Sbrana, Beatrice Dal Pino, Federico Bigazzi, Andrea Ripoli, Paolo Marzullo & Alessia Gimelli. (2022) Coronary microcirculatory blood flow significantly increases upon acute and chronic cholesterol lowering: evaluation by cadmium–zinc–telluride cardiac imaging stress test. European Journal of Preventive Cardiology.
Crossref
Crossref
Maria Francesca Greco, Cesare R. Sirtori, Alberto Corsini, Marat Ezhov, Tiziana Sampietro & Massimiliano Ruscica. (2020) Lipoprotein(a) Lowering—From Lipoprotein Apheresis to Antisense Oligonucleotide Approach. Journal of Clinical Medicine 9:7, pages 2103.
Crossref
Crossref
Sergey Tselmin, Ulrich Julius, Nadine Weinert, Stefan R. Bornstein & Ulrike Schatz. (2019) Experience with proprotein convertase subtilisin/kexine type 9 inhibitors (PCSK9i) in patients undergoing lipoprotein apheresis. Atherosclerosis Supplements 40, pages 38-43.
Crossref
Crossref
Fei Fang, Xiao-Jun Huang, Yi-Zong Guo, Xiao Hong, Hui-Min Wu, Rong Liu & Da-Jing Chen. (2018) Selective and Regenerable Surface Based on β-Cyclodextrin for Low-Density Lipoprotein Adsorption. Langmuir 34:28, pages 8163-8169.
Crossref
Crossref
U. Schatz, S. Tselmin, G. Müller, U. Julius, B. Hohenstein, S. Fischer & S.R. Bornstein. (2017) Most significant reduction of cardiovascular events in patients undergoing lipoproteinapheresis due to raised Lp(a) levels – A multicenter observational study. Atherosclerosis Supplements 30, pages 246-252.
Crossref
Crossref
Tiziana Sampietro, Francesco Sbrana, Emilio Maria Pasanisi, Federico Bigazzi, Christina Petersen, Michele Coceani, Beatrice Dal Pino, Andrea Ripoli, Mascia Pianelli & Roberta Luciani. (2017) LDL apheresis improves coronary flow reserve on the left anterior descending artery in patients with familial hypercholesterolemia and chronic ischemic heart disease. Atherosclerosis Supplements 30, pages 135-140.
Crossref
Crossref
Steffi Kopprasch, Stefan R. Bornstein, Sybille Bergmann, Juergen Graessler, Bernd Hohenstein & Ulrich Julius. (2017) Long-term follow-up of circulating oxidative stress markers in patients undergoing lipoprotein apheresis by Direct Adsorption of Lipids (DALI). Atherosclerosis Supplements 30, pages 115-121.
Crossref
Crossref
S. Jellinghaus, C. Reich, U. Schatz, S. Tselmin, K. Ibrahim, C. Pfluecke, A. Schauer, S.R. Bornstein, B. Hohenstein, R.H. Strasser, U. Julius & D.M. Poitz. (2017) Lipoprotein apheresis influences monocyte subpopulations. Atherosclerosis Supplements 30, pages 108-114.
Crossref
Crossref
Francesco Sbrana, Beatrice Dal Pino, Federico Bigazzi, Andrea Ripoli, Claudio Passino, Alessandra Gabutti, Emilio M Pasanisi, Christina Petersen, Alessandro Valleggi, Giancarlo Todiere, Andrea Barison, Alberto Giannoni, Luca Panchetti, Francesco Becherini, Mascia Pianelli, Roberta Luciani & Tiziana Sampietro. (2017) Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else?. European Journal of Preventive Cardiology 24:14, pages 1528-1531.
Crossref
Crossref
Claudia Stefanutti, Ulrich Julius, Gerald F. Watts, Mariko Harada-Shiba, Maria Cossu, Volker J. Schettler, Giustina De Silvestro, Handrean Soran, Jeanine Roeters Van Lennep, Livia Pisciotta, Hans U. Klör, Kurt Widhalm, Patrick M. Moriarty, Giovanna D'Alessandri, Giorgio Bianciardi, Giovanna Bosco, Giulia De Fusco, Serafina Di Giacomo, Claudia Morozzi, Dario Mesce, Marco Vitale, Barbara Sovrano, Euridiki Drogari, Nils Ewald, Gianfranco Gualdi, Beate R. Jaeger, Alessandro Lanti, Piero Marson, Francesco Martino, Giuseppe Migliori, Tiziano Parasassi, Antonio Pavan, Francesco Massimo Perla, Roberto Brunelli, Giuseppina Perrone, Salvatorica Renga, Wolfgang Ries, Nicola Romano, Stefano Romeo, Mario Pergolini, Giancarlo Labbadia, Biagio Di Iorio, Tommaso De Palo, Rosanna Abbate, Rossella Marcucci, Lorella Poli, Gianluigi Ardissino, Piero Ottone, Tiziana Tison, Elda Favari, Leonardo Borgese, Manhaz Shafii, Maria Gozzer, Elena Pacella, Concetta Torromeo, Tiziana Parassassi, Andrea Berni, Ornella Guardamagna, Maria Grazia Zenti, Maria Rita Guitarrini, Daniele Berretti, Bernd Hohenstein, Samir Saheb, Bojko Bjelakovic, Helen Williams & De Luca N. (2017) Toward an international consensus—Integrating lipoprotein apheresis and new lipid-lowering drugs. Journal of Clinical Lipidology 11:4, pages 858-871.e3.
Crossref
Crossref
Fei Fang, Xue-Yan Zhu, Chen Chen, Jing Li, Da-Jing Chen & Xiao-Jun Huang. (2017) Anionic glycosylated polysulfone membranes for the affinity adsorption of low-density lipoprotein via click reactions. Acta Biomaterialia 49, pages 379-387.
Crossref
Crossref
Michael France, Alan Rees, Dev Datta, Gilbert Thompson, Nigel Capps, Gordon Ferns, Uma Ramaswami, Mary Seed, Dermot Neely, Robert Cramb, Carol Shoulders, Mahmoud Barbir, Alison Pottle, Ruth Eatough, Steven Martin, Graham Bayly, Bill Simpson, Julian Halcox, Ray Edwards, Linda Main, Jules Payne & Handrean Soran. (2016) HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom. Atherosclerosis 255, pages 128-139.
Crossref
Crossref
Liwei Wang, Fei Fang, Yang Liu, Jing Li & Xiaojun Huang. (2016) Facile preparation of heparinized polysulfone membrane assisted by polydopamine/polyethyleneimine co-deposition for simultaneous LDL selectivity and biocompatibility. Applied Surface Science 385, pages 308-317.
Crossref
Crossref
T. Sampietro, F. Sbrana, F. Bigazzi, A. Ripoli, B. Dal Pino, E.M. Pasanisi, C. Petersen, M. Coceani, R. Luciani & M. Pianelli. (2015) The incidence of cardiovascular events is largely reduced in patients with maximally tolerated drug therapy and lipoprotein apheresis. A single-center experience. Atherosclerosis Supplements 18, pages 268-272.
Crossref
Crossref
Ursula Kassner, Thomas Schlabs, Adrian Rosada & Elisabeth Steinhagen-Thiessen. (2015) Lipoprotein(a) – An independent causal risk factor for cardiovascular disease and current therapeutic options. Atherosclerosis Supplements 18, pages 263-267.
Crossref
Crossref
U. Emmrich, B. Hohenstein & U. Julius. (2015) Actual situation of lipoprotein apheresis in Saxony in 2013. Atherosclerosis Supplements 18, pages 215-225.
Crossref
Crossref
S. Schampera, S. Fischer, N. Weiss & U. Julius. (2015) Detailed description of the cardiovascular situation in patients who have started lipoprotein apheresis treatment. Atherosclerosis Supplements 18, pages 209-214.
Crossref
Crossref
U. Schatz, B.M.W. Illigens, T. Siepmann, B. Arneth, G. Siegert, D. Siegels, F. Heigl, R. Hettich, W. Ramlow, H. Prophet, S.R. Bornstein & U. Julius. (2015) TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients – A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose. Atherosclerosis Supplements 18, pages 199-208.
Crossref
Crossref
U. Julius, M. Milton, D. Stoellner, D. Rader, B. Gordon, D. Polk, E. Waldmann, K.G. Parhofer & P.M. Moriarty. (2015) Effects of lipoprotein apheresis on PCSK9 levels. Atherosclerosis Supplements 18, pages 180-186.
Crossref
Crossref
U. Julius, G. Siegert, H. Kostka, U. Schatz & B. Hohenstein. (2015) Effects of different lipoprotein apheresis methods on serum protein levels. Atherosclerosis Supplements 18, pages 95-102.
Crossref
Crossref
Steffi Kopprasch, Stefan R. Bornstein, Sybille Bergmann, Juergen Graessler & Ulrich Julius. (2015) Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters – A comparison of two different apheresis techniques. Atherosclerosis Supplements 18, pages 80-84.
Crossref
Crossref
J. Dittrich-Riediger, U. Schatz, B. Hohenstein & U. Julius. (2015) Adverse events of lipoprotein apheresis and immunoadsorption at the Apheresis Center at the University Hospital Dresden. Atherosclerosis Supplements 18, pages 45-52.
Crossref
Crossref
Yang Liu, Wen-Ze Qiu, Hao-Cheng Yang, Yue-Cheng Qian, Xiao-Jun Huang & Zhi-Kang Xu. (2015) Polydopamine-assisted deposition of heparin for selective adsorption of low-density lipoprotein. RSC Advances 5:17, pages 12922-12930.
Crossref
Crossref
L.G. P’yanova, V.A. Likholobov & A.V. Sedanova. (2015) Perspective Directions of Synthesis of Materials with Biospecific Actions Based on Nanodispersed Carbon. Procedia Engineering 113, pages 466-473.
Crossref
Crossref